Biohellenika was audited online on 16/12/2020 and 17/12/2020 for continued international accreditation by the AABB (American Association of Blood Banks). The assessment was done online and took longer than normal, due to the virtual process. Biohellenika has successfully completed the two-day evaluation process and continues to belong to the internationally accredited cord blood stem cell banks. It is the 6th consecutive successful evaluation of Biohellenika by AABB and its renewal will take place in 2022.
Biohellenika renews the AABB accreditation continuously since 2010.
It is also in the process of being accredited by FACT NetCord, which is another international accreditation that includes the allogeneic use of stem cells.
It is also accredited by the National Accreditation System (ESYD) for all the tests provided by law, which are required for the storage of umbilical cord blood stem cells.
The company also completes the GMP (Good Manufacturing Practice) processes for its development into a Tissue Bank and a Biotechnology company.